American Oncology Network Earlier Reported It Will Voluntary Delist From Nasdaq; Expects That The Last Trading Day Of Its Class A Common Stock And Warrants On Nasdaq Will Be On Or About June 7, 2024.
American Oncology Network Earlier Reported It Will Voluntary Delist From Nasdaq; Expects That The Last Trading Day Of Its Class A Common Stock And Warrants On Nasdaq Will Be On Or About June 7, 2024.
American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company's decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board comprised solely of independent directors.
快速發展的社區腫瘤學實踐網絡美國腫瘤學網絡（“AON” 或 “公司”）（納斯達克股票代碼：AONC）今天宣佈決定自願從納斯達克資本市場（“納斯達克”）退市其A類普通股和認股權證。公司決定將其證券從納斯達克退市是由一個僅由獨立董事組成的董事會特別委員會（“特別委員會”）向公司董事會（“董事會”）建議的。
The Company intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") to delist its Class A common stock and warrants from Nasdaq and to deregister its Class A common stock and warrants under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), on or about May 31, 2024, and as a result, the Company expects that the last trading day of its Class A common stock and warrants on Nasdaq will be on or about June 7, 2024.
公司打算在2024年5月31日左右向美國證券交易委員會（“SEC”）提交25號表格，將其A類普通股和認股權證從納斯達克退市，並根據經修訂的1934年《證券交易法》（“交易法”）第12（b）條註銷其A類普通股和認股權證，因此，公司預計其A類普通股的最後一個交易日是其A類普通股和認股權證納斯達克的普通股和認股權證將於2024年6月7日左右上市。
譯文內容由第三人軟體翻譯。